top1630
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 20, 2017 (NCT03088605)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- top1630
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03833388 | Phase 2/Phase 3 (Phase 3) | Feb 13, 2019 | Topivert Pharma Ltd |
| NCT03088605 | Phase 2 | Feb 20, 2017 | Andover Eye Associates, Topivert Pharma Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Topivert Pharma Ltd | For profit | 2 | 2 | 2 | 2017 |
| Andover Eye Associates | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1